NCT06160479

Brief Summary

Calcium is an essential element for fundamental physiological functions and during pregnancy. However, higher calcium intake can induce constipation, flatulence, nausea, or kidney stones. This study aims to evaluate the incidence of hypocalcemia among pregnant women in the first half of pregnancy in Thailand. Also, Comparison of calcium level in pregnant women in the third trimester who received and not received calcium during pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
444

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 27, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 7, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

December 7, 2023

Status Verified

December 1, 2023

Enrollment Period

1.4 years

First QC Date

November 27, 2023

Last Update Submit

December 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of hypocalcemia in pregnant women at Siriraj Hospital

    The incidence of hypocalcemia in pregnant women in the first half of pregnancy. Material blood will be taken for calcium level. The hypocalcemia is defined as total calcium level less than 8.5 mg/dl.

    1.5 year

Secondary Outcomes (2)

  • The demographic and pregnant factors are associating with maternal calcium level in the first half of pregnancy assessed by the questionnaire and scrupulous chart review

    1.5 year

  • The calcium level in pregnant women in the third trimester

    2 year

Study Arms (4)

Normal calcium level with no receiving calcium supplement

NO INTERVENTION

Pregnant women with normal calcium level in the first half of pregnancy do not receive calcium supplement.

Normal calcium level with receiving calcium supplement 1g/day

EXPERIMENTAL

Pregnant women with normal calcium level in the first half of pregnancy receive calcium supplement 1g/day.

Drug: Calcium supplement

Hypocalcemia with receiving calcium supplement 1g/day

EXPERIMENTAL

Pregnant women with hypocalcemia in the first half of pregnancy receive calcium supplement 1g/day.

Drug: Calcium supplement

Hypocalcemia level with receiving calcium supplement 2g/day

EXPERIMENTAL

Pregnant women with hypocalcemia in the first half of pregnancy receive calcium supplement 2g/day.

Drug: Calcium supplement

Interventions

Different amount of calcium supplement in pregnancy

Hypocalcemia level with receiving calcium supplement 2g/dayHypocalcemia with receiving calcium supplement 1g/dayNormal calcium level with receiving calcium supplement 1g/day

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women who attend antenatal care clinic in Siriraj Hospital
  • Pregnant women with gestation less than 20 weeks of gestation
  • Singleton pregnancy

You may not qualify if:

  • Pregnant women who has underlying diseases including liver disease and vitamin D deficiency
  • Pregnant women are malnutrition patients
  • Pregnant women who receive calcium supplement before enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Siriraj Hospital

Bangkoknoi, Bangkok, 10700, Thailand

Location

Study Officials

  • Tachjaree Panchalee, MD

    Siriraj Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor Tachjaree Panchalee

Study Record Dates

First Submitted

November 27, 2023

First Posted

December 7, 2023

Study Start

May 5, 2022

Primary Completion

September 12, 2023

Study Completion

May 31, 2024

Last Updated

December 7, 2023

Record last verified: 2023-12

Locations